Hypoxia as a key player in the AKI-to-CKD transition von Tanaka, Shinji, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

PHD in the FOXD1 lineage cells links hypoxia to inappropriate nephrogenesis von Tanaka, Tetsuhiro

Volltext

Expanding roles of the hypoxia-response network in chronic kidney disease von Tanaka, Tetsuhiro

Volltext

A mechanistic link between renal ischemia and fibrosis von Tanaka, Tetsuhiro

Volltext

Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease von Sugahara, Mai, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

Treatment of Diabetic Kidney Disease: Current and Future von Yamazaki, Tomotaka, Mimura, Imari, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors von Sugahara, Mai, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice von Tanaka, Shinji, Sugiura, Yuki, Saito, Hisako, Sugahara, Mai, Higashijima, Yoshiki, Yamaguchi, Junna, Inagi, Reiko, Suematsu, Makoto, Nangaku, Masaomi, Tanaka, Tetsuhiro

Volltext

What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances von Watanabe, Kimio, Sato, Emiko, Mishima, Eikan, Miyazaki, Mariko, Tanaka, Tetsuhiro

Volltext

Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage von Ito, Marie, Tanaka, Tetsuhiro, Ishii, Taisuke, Wakashima, Takeshi, Fukui, Kenji, Nangaku, Masaomi

Volltext

The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors von Ito, Marie, Tanaka, Tetsuhiro

Volltext

Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidney von Ishimoto, Yu, Tanaka, Tetsuhiro, Yoshida, Yoko, Inagi, Reiko

Volltext

Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease von Hasegawa, Sho, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice von Sugahara, Mai, Tanaka, Shinji, Tanaka, Tetsuhiro, Saito, Hisako, Ishimoto, Yu, Wakashima, Takeshi, Ueda, Masatoshi, Fukui, Kenji, Shimizu, Akira, Inagi, Reiko, Yamauchi, Toshimasa, Kadowaki, Takashi, Nangaku, Masaomi

Volltext

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods von Hirakawa, Yosuke, Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

Regulatory roles of hypoxia-inducible, noncoding RNAs on mitochondrial dynamics during AKI von Tanaka, Tetsuhiro, Nangaku, Masaomi

Volltext

The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease von Hasegawa, Sho, Tanaka, Tetsuhiro, Saito, Tomoyuki, Fukui, Kenji, Wakashima, Takeshi, Susaki, Etsuo A., Ueda, Hiroki R., Nangaku, Masaomi

Volltext

Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease von Uchida, Lisa, Tanaka, Tetsuhiro, Saito, Hisako, Sugahara, Mai, Wakashima, Takeshi, Fukui, Kenji, Nangaku, Masaomi

Volltext

Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury von Higashijima, Yoshiki, Tanaka, Tetsuhiro, Yamaguchi, Junna, Tanaka, Shinji, Nangaku, Masaomi

Volltext

Update on diagnosis, pathophysiology, and management of diabetic kidney disease von Sugahara, Mai, Pak, Wai Lun Will, Tanaka, Tetsuhiro, Tang, Sydney C. W., Nangaku, Masaomi

Volltext